136 related articles for article (PubMed ID: 9175908)
1. Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients.
Folzenlogen D; Hofer MF; Leung DY; Freed JH; Newell MK
Clin Immunol Immunopathol; 1997 Jun; 83(3):199-204. PubMed ID: 9175908
[TBL] [Abstract][Full Text] [Related]
2. Differential expression and modulation of costimulatory molecules CD80 and CD86 on monocytes from patients with systemic lupus erythematosus.
Liu MF; Li JS; Weng TH; Lei HY
Scand J Immunol; 1999 Jan; 49(1):82-7. PubMed ID: 10023862
[TBL] [Abstract][Full Text] [Related]
3. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.
Bijl M; Horst G; Limburg PC; Kallenberg CG
Ann Rheum Dis; 2001 May; 60(5):523-6. PubMed ID: 11302879
[TBL] [Abstract][Full Text] [Related]
4. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
Nagafuchi H; Shimoyama Y; Kashiwakura J; Takeno M; Sakane T; Suzuki N
Clin Exp Rheumatol; 2003; 21(1):71-7. PubMed ID: 12673892
[TBL] [Abstract][Full Text] [Related]
5. [Costimulatory molecule expression on allergen-stimulated PBMC in cedar pollinosis subjects].
Morikawa H; Baba K
Nihon Jibiinkoka Gakkai Kaiho; 2001 Mar; 104(3):198-207. PubMed ID: 11305050
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD80/CD86 and CTLA-4 mRNA in peripheral blood mononuclear cells of the patients with systemic lupus erythematosus.
Liu W; Li J
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(3):247-9. PubMed ID: 15315339
[TBL] [Abstract][Full Text] [Related]
7. CD80 (B7-1) and CD86 (B7-2) expression in multiple sclerosis patients: clinical subtype specific variation in peripheral monocytes and B cells and lack of modulation by high dose methylprednisolone.
Boylan MT; Crockard AD; McDonnell GV; Armstrong MA; Hawkins SA
J Neurol Sci; 1999 Aug; 167(2):79-89. PubMed ID: 10521545
[TBL] [Abstract][Full Text] [Related]
8. CD80 and CD86 costimulatory molecules on circulating T cells of HIV infected individuals.
Köchli C; Wendland T; Frutig K; Grunow R; Merlin S; Pichler WJ
Immunol Lett; 1999 Feb; 65(3):197-201. PubMed ID: 10065743
[TBL] [Abstract][Full Text] [Related]
9. The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigen.
Engel P; Gribben JG; Freeman GJ; Zhou LJ; Nozawa Y; Abe M; Nadler LM; Wakasa H; Tedder TF
Blood; 1994 Sep; 84(5):1402-7. PubMed ID: 7520767
[TBL] [Abstract][Full Text] [Related]
10. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
Wong CK; Lit LC; Tam LS; Li EK; Lam CW
Rheumatology (Oxford); 2005 Aug; 44(8):989-94. PubMed ID: 15870153
[TBL] [Abstract][Full Text] [Related]
11. CD86 (B7-2) antigen on B cells from atopic patients shows selective, antigen-specific upregulation.
Nakada M; Nishizaki K; Yoshino T; Okano M; Masuda Y; Ohta N; Akagi T
Allergy; 1998 May; 53(5):527-31. PubMed ID: 9636813
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD80 and CD86 on peripheral blood T lymphocytes in patients with systemic lupus erythematosus.
Abe K; Takasaki Y; Ushiyama C; Asakawa J; Fukazawa T; Seki M; Hirashima M; Ogaki M; Hashimoto H
J Clin Immunol; 1999 Jan; 19(1):58-66. PubMed ID: 10080105
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood antigen-presenting cells from African-Americans exhibit increased CD80 and CD86 expression.
Hutchings A; Purcell WM; Benfield MR
Clin Exp Immunol; 1999 Nov; 118(2):247-52. PubMed ID: 10540186
[TBL] [Abstract][Full Text] [Related]
14. Antigen receptor triggered upregulation of CD86 and CD80 in human B cells: augmenting role of the CD21/CD19 co-stimulatory complex and IL-4.
Mongini PK; Tolani S; Fattah RJ; Inman JK
Cell Immunol; 2002; 216(1-2):50-64. PubMed ID: 12381350
[TBL] [Abstract][Full Text] [Related]
15. Changes in the number of CD80(+), CD86(+), and CD28(+) peripheral blood lymphocytes have prognostic value in melanoma patients.
Martínez-Escribano JA; Hernández-Caselles T; Campillo JA; Campos M; Frías JF; García-Alonso A; Alvarez-López MR
Hum Immunol; 2003 Aug; 64(8):796-801. PubMed ID: 12878358
[TBL] [Abstract][Full Text] [Related]
16. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
[TBL] [Abstract][Full Text] [Related]
17. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule.
Nakajima A; Azuma M; Kodera S; Nuriya S; Terashi A; Abe M; Hirose S; Shirai T; Yagita H; Okumura K
Eur J Immunol; 1995 Nov; 25(11):3060-9. PubMed ID: 7489744
[TBL] [Abstract][Full Text] [Related]
18. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells.
Caux C; Vanbervliet B; Massacrier C; Azuma M; Okumura K; Lanier LL; Banchereau J
J Exp Med; 1994 Nov; 180(5):1841-7. PubMed ID: 7525840
[TBL] [Abstract][Full Text] [Related]
19. CD80 (B7-1) and CD86 (B7-2) antigens on house dust mite-specific T cells in atopic disease function through T-T cell interactions.
Nakada M; Nishizaki K; Yoshino T; Okano M; Yamamoto T; Masuda Y; Ohta N; Akagi T
J Allergy Clin Immunol; 1999 Jul; 104(1):222-7. PubMed ID: 10400865
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of human B lymphocyte activities by a Trypanosoma cruzi membrane glycoprotein.
Kierszenbaum F; Sztein MB
Int J Parasitol; 2001 Mar; 31(3):265-71. PubMed ID: 11226453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
